Practice management committee explains Medicare patients' access to new technology
April 16th 2005Washington, DC — The American Society of Cataract and Refractive Surgery (ASCRS) issued a paper last year regarding the mission to deliver safe and effective cataract surgery services to all Medicare patients and that all beneficiaries have the right to "essential services," explained Priscilla P. Arnold, MD, immediate past president of ASCRS and the chairman of the government relations committee.
Bilateral cataract surgery practiced in 'revenue neutral' arenas
April 16th 2005Washington, DC — Simultaneous bilateral cataract surgery offers increased efficiency over unilateral cataract surgery by as much as 15%. However, practitioners are slow to adopt this procedure because of low reimbursements, explained Steve A. Arshinoff, MD, a practitioner based in Toronto, during the refractive/cataract socioeconomic symposium held at the American Society of Cataract and Refractive Surgery annual meeting.
Health of the ophthalmic market remains 'strong'
April 16th 2005Washington, DC — The ophthalmic industry was given a sound bill of health in an independent analysis of the market. Kenneth P. Taylor, OD, provided an overview of the ophthalmic market in terms of trends, growth, and the view from Wall Street in a presentation at the American Society of Cataract and Refractive Surgery annual meeting.
Surface ablation emerging as safe alternative for select patients
April 16th 2005Washington, DC — LASIK remains the refractive procedure of choice for the majority of refractive surgeons and patients worldwide. However, surface ablation is a reasonable alternative that may even offer some advantages overall and be a preferred technique in select patients, said Helen K. Wu, MD, at the American Society of Cataract and Refractive Surgery meeting.
Dr. Steinert assumes ASCRS presidency, sends message of 'inclusion'
April 16th 2005Washington, DC — It's an annual rite of spring: each year the American Society of Cataract and Refractive Surgery (ASCRS) passes the baton from one leader to another. Roger Steinert, MD, assumed the presidency of the society during its general session Saturday morning.
Diaphragm implant safely changes color of iris
April 15th 2005Panama City, Panama—An artificial iris dia-phragm implant (NewIris, Kahn Medical Devices) that changes the color of the eyes is safe, easy to implant, well tolerated, and has a more natural appearance than contact lenses, said Delary A. Kahn, MD.
A drug with few side effects can cure multiple ills
April 15th 2005When I was a boy, my father mentioned several times how he might have purchased IBM stock decades earlier, and how much such an investment would have been worth at the time. Often, people tell me how they refrained from purchasing a waterfront home because the price seemed way too steep, only to have the value subsequently shoot up 10-fold. Perhaps we all regret not making certain purchases long ago.
Acute orbital, periorbital pain may signal arterial dissection
April 15th 2005Atlanta—Arterial dissection can be overlooked in a patient who presents to an ophthalmologist with acute orbital or periorbital pain. Val?rie Biousse, MD, described the appropriate steps to take to ensure an accurate diagnosis and avoid a subsequent cerebral insult.
Consider volume augmentation in PESS
April 15th 2005Austin, TX—Volume loss is an important aspect of post-enucleation socket syndrome (PESS), resulting from the inability of the prosthetic orbital implant to replace all of the volume lost from an enucleated or eviscerated socket. Fortunately, there are a number of effective techniques for volume augmentation in PESS, said John Shore, MD, FACS, who is in practice with Texas Oculoplastic Consultants, Austin, TX.
Multiple factors underlie non-compliance with treatment
April 15th 2005Dorado Beach, Puerto Rico—Recognizing that non-compliance and non-adherence are common among patients being treated with medical therapy for glaucoma, clinicians need to determine if medication is being used as prescribed, and if not, the reasons why, said Marshall N. Cyrlin, MD, at the Current Concepts in Ophthalmology meeting, sponsored by Johns Hopkins University School of Medicine and Ophthalmology Times.
No need to treat every patient with ocular hypertension
April 15th 2005St. Louis—The main lesson to be learned from the Ocular Hypertension Treatment Study (OHTS) is that not every patient with ocular hypertension needs to be treated, according to Michael A. Kass, MD, a professor in the department of ophthalmology and visual sciences at Washington University in St. Louis, and chairman of the groundbreaking large-scale study.
Updated mindset needed to combat glaucoma successfully
April 15th 2005New approaches to early detection, diagnosis, and management are essential to deal with the public health problem of glaucoma, the leading cause of blindness in the United States. Speakers at a continuing education symposium held during the American Academy of Ophthalmology meeting discussed topics such as the glaucoma continuum, application of the results of large clinical trials, global risk assessment principles, and pharmacotherapy.
Wavefront-guided LASIK better than conventional, but why?
April 15th 2005Wavefront-guided LASIK yields more accurate corrections and better quality of vision compared with conventional LASIK regardless of which laser system is used, said Robert K. Maloney, MD, at the American Academy of Ophthalmology refractive surgery subspecialty day meeting in New Orleans.
Interim results of hyperopic LASIK trial highly favorable
April 15th 2005Atlanta—Interim study analyses from a multicenter, North American trial indicate LASIK for treatment of hyperopia with or without astigmatism using the Nidek EC-5000 excimer laser is associated with consistently good safety and efficacy outcomes, reported George O. Waring III, MD, the medical monitor for the study.
Endophthalmitis higher with CCI than scleral tunnel
April 15th 2005San Francisco—A number of studies have suggested an increased rate of endophthalmitis with clear cornea surgery compared with scleral tunnel surgery, and potential causes of this increase include incision location, incision architecture and changes in antibiotic prophylaxis, according to David G. Hwang, MD.
Thoughts on transition to bimanual phaco
April 15th 2005For the past few years, the lure of ever smaller incisions has enticed cataract surgeons who perform temporal, clear corneal phacoemulsification with topical anesthesia. With a variety of shooters, we have been placing IOLs through 2.5- to 2.8-mm incisions and we feel comfortable with our self-sealing wounds and good results. Still, as many of us recall with previous transitions in our cataract surgery development, taking on a new skill requires stepping out of one's comfort zone to take advantage of even better technology. Such has been the situation with bimanual phacoemulsification.